Reply of the authors

Affiliations

¹ Department of Reproductive Medicine and Gynecological Endocrinology, University Clinic of Schleswig-Holstein, Luebeck, Germany.
² MSD, Oss, the Netherlands.
³ Laboratory of Reproductive Biology, University Hospital of Copenhagen, Copenhagen, Denmark.
⁴ Unit for Human Reproduction, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁵ Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey.

Free article

Comment

Georg Griesinger et al. Fertil Steril. 2014 Jan.

Free article

. 2014 Jan;101(1):e5-6.

doi: 10.1016/j.fertnstert.2013.10.037. Epub 2013 Nov 26.

¹ Department of Reproductive Medicine and Gynecological Endocrinology, University Clinic of Schleswig-Holstein, Luebeck, Germany.
² MSD, Oss, the Netherlands.
³ Laboratory of Reproductive Biology, University Hospital of Copenhagen, Copenhagen, Denmark.
⁴ Unit for Human Reproduction, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁵ Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey.

No abstract available

Comment on

Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.
Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K. Griesinger G, et al. Fertil Steril. 2013 Dec;100(6):1622-8.e1-3. doi: 10.1016/j.fertnstert.2013.08.045. Epub 2013 Sep 29. Fertil Steril. 2013. PMID: 24083873
Does progesterone elevation compromise pregnancy rates in high responders? Insufficient evidence to draw a conclusion.
Bosch E. Bosch E. Fertil Steril. 2014 Jan;101(1):e3-4. doi: 10.1016/j.fertnstert.2013.10.036. Epub 2013 Nov 26. Fertil Steril. 2014. PMID: 24289998 No abstract available.